Related Experiment Video
Updated: Jul 1, 2025
10:21
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
10.0K
Obstruction in Hypertrophic Cardiomyopathy: Many Faces.
Muhannad Abbasi1, Kevin C Ong2, D Brian Newman1
1Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Summary
Hypertrophic cardiomyopathy (HCM) involves thickened heart muscle, often causing outflow obstruction. Echocardiography, particularly Doppler, is key for diagnosing, managing, and monitoring this inherited condition.
Area of Science:
- Cardiology
- Inherited cardiovascular diseases
Background:
- Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy.
- It is characterized by left ventricular hypertrophy not caused by other conditions.
- Enhanced actin-myosin interaction leads to excessive myocardial contraction and potential left ventricular outflow tract obstruction.
Purpose of the Study:
- To explore the role of echocardiography in evaluating HCM.
- To emphasize Doppler assessment for identifying and monitoring left ventricular outflow tract obstruction.
- To guide therapeutic decision-making through noninvasive hemodynamic assessment.
Main Methods:
- Utilizing transthoracic echocardiography for screening, diagnosis, and risk stratification.
- Employing Doppler echocardiography to assess dynamic obstruction.
- Incorporating provocative maneuvers for hemodynamic assessment.
- Reviewing echocardiographic findings in relation to anatomical abnormalities.
Main Results:
- Left ventricular outflow tract obstruction occurs in 75% of HCM patients, impacting prognosis and symptoms.
- Echocardiography provides crucial noninvasive hemodynamic assessment.
- Doppler assessment is vital for monitoring responses to medical and interventional therapies.
Conclusions:
- Echocardiography is indispensable in the comprehensive management of HCM.
- Doppler assessment of obstruction is critical for guiding treatment strategies.
- Recognition of obstructive HCM phenotypes informs therapeutic choices, including medical and septal reduction therapies.
Keywords:
DopplerEchocardiographyHypertrophic cardiomyopathyLeft ventricular outflow tract obstructionMyectomyMore Related Videos
Related Concept Videos
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
01:22Heart Failure Drugs: β-Blockers
338
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
338
01:17Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K